Month: September 2020

Opioid Manufacturer Mallinckrodt Heading Towards Bankruptcy

Opioid drug manufacturer Mallinckrodt PLC may seek Chapter 11 bankruptcy protection as the latest casualty in the nationwide opioid crisis. According to a recent article by Bloomberg, the company is working with external advisers, creditors and litigation claimants and is considering all options to address legal and financial challenges. The bankruptcy filing is expected to …

Opioid Manufacturer Mallinckrodt Heading Towards Bankruptcy Read More »

Zantac Litigation: What you need to know

Prior to being recalled in early 2020, Zantac was one of the most widely used medications for the treatment of heartburn, acid reflux and acid related digestive issues. Chemically known as ranitidine hydrochloride, Zantac (or ranitidine) is a class of drugs called histamine H2-receptor antagonists (H2 blockers), which decrease the body’s production of stomach acid, …

Zantac Litigation: What you need to know Read More »